BRNS vs VNO · $38.2M cap vs rev $921.3M
Barinthus Biotherapeutics plc (BRNS) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
BRNS currently screens at market cap $38.2M. VNO currently screens at market cap $0.
Not investment advice. Open the BRNS and VNO stock pages for the full models.
Not investment advice.